CPAY vs MDB vs VRSN
161 measures in 16 categories, one definition each, computed from filings and market data.
VRSN56.4
VeriSign, Inc.
Technology · Software - Infrastructure
$302.33 −0.58%$27.3B mkt cap
Score DNA
Price, rebased to 100 three years ago
CPAY MDB VRSN · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | CPAY | MDB | VRSN |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 4 |
| Insider $ bought, 180d | — | — | $0.01M |
| Congress purchases, 180d | 0 | 2 | 0 |
| Last Congress purchase | — | 2026-09-25 | — |
| 13F net change in holders | +52 | +60 | +29 |
| ETFs adding shares, 30d | 995 | 870 | 1,033 |
| ETFs trimming, 30d | 852 | 618 | 891 |
| Net ETF funds, 30d | +143 | +252 | +142 |
Valuation
16 measures| Measure | CPAY | MDB | VRSN |
|---|---|---|---|
| P/E (TTM) | 23.0x
43rd
|
461.0x
95th
|
32.2x
52nd
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 1.99
81st
|
— | 2.98
100th
|
| Price / sales | 5.2x
62nd
|
9.8x
83rd
|
16.0x
93rd
|
| Price / book | 7.4x
70th
|
9.1x
77th
|
— |
| Price / tangible book | — | 10.1x
46th
|
— |
| Price / free cash flow | 16.0x
43rd
|
40.7x
79th
|
25.6x
61st
|
| Price / operating cash flow | 14.2x
54th
|
40.2x
86th
|
24.8x
69th
|
| Enterprise value | $33.7B
86th
|
$24.8B
81st
|
$28.6B
83rd
|
| EV / sales | 6.7x
67th
|
8.9x
75th
|
16.8x
94th
|
| EV / EBITDA | 13.2x
37th
|
220.7x
99th
|
23.8x
65th
|
| EV / EBIT | 16.0x
31st
|
320.6x
97th
|
24.4x
48th
|
| EV / free cash flow | 20.6x
51st
|
37.1x
73rd
|
26.9x
61st
|
| Earnings yield | 4.3%
67th
|
0.2%
26th
|
3.1%
59th
|
| FCF yield | 6.2%
62nd
|
2.5%
30th
|
3.9%
46th
|
| Operating cash flow yield | 7.0%
48th
|
2.5%
17th
|
4.0%
33rd
|
| Graham number (per share) | $143.76
98th
|
$24.24
68th
|
— |
Profitability (TTM)
12 measures| Measure | CPAY | MDB | VRSN |
|---|---|---|---|
| Gross margin | 73.3%
63rd
|
72.7%
58th
|
88.5%
100th
|
| EBITDA margin | 50.8%
94th
|
4.0%
15th
|
70.4%
100th
|
| Operating margin | 40.8%
93rd
|
-0.5%
23rd
|
67.9%
100th
|
| EBIT margin | 42.0%
95th
|
2.8%
25th
|
68.8%
100th
|
| Net margin | 22.7%
84th
|
2.1%
31st
|
49.8%
99th
|
| NOPAT margin | 28.1%
86th
|
-0.4%
23rd
|
52.3%
100th
|
| FCF margin | 32.6%
88th
|
24.0%
64th
|
62.4%
100th
|
| Operating cash flow margin | 36.8%
80th
|
24.3%
52nd
|
64.5%
94th
|
| R&D / revenue | 0.0%
0th
|
28.0%
88th
|
6.3%
30th
|
| SG&A / revenue | 27.5%
40th
|
45.2%
68th
|
14.3%
14th
|
| Stock comp / revenue | 2.3%
21st
|
20.3%
90th
|
0.3%
1st
|
| Effective tax rate | 31.2%
87th
|
22.0%
73rd
|
23.0%
77th
|
Returns on capital
11 measures| Measure | CPAY | MDB | VRSN |
|---|---|---|---|
| ROE (on average equity) | 30.5%
77th
|
2.0%
25th
|
— |
| ROA | 4.7%
49th
|
1.6%
36th
|
52.9%
100th
|
| ROIC | 12.8%
57th
|
-1.9%
22nd
|
-94.2%
6th
|
| ROCE | 18.7%
84th
|
2.5%
28th
|
-1,220.4%
0th
|
| Return on tangible assets | 8.7%
68th
|
2.1%
28th
|
73.2%
100th
|
| Cash ROIC (OCF / invested capital) | 16.8%
30th
|
113.0%
77th
|
— |
| Gross profitability (GP / assets) | 13.0%
11th
|
53.5%
84th
|
83.8%
99th
|
| ROIC, 3-yr average | 11.9%
69th
|
-45.4%
2nd
|
— |
| ROIC, 5-yr average | 16.9%
65th
|
-7.6%
17th
|
— |
| ROE, 5-yr average | 31.8%
92nd
|
-19.6%
15th
|
— |
| Incremental ROIC | 32.4%
51st
|
167.5%
87th
|
96.0%
76th
|
Growth
17 measures| Measure | CPAY | MDB | VRSN |
|---|---|---|---|
| Revenue growth (TTM YoY) | 20.4%
62nd
|
25.5%
79th
|
6.9%
25th
|
| Revenue growth (QoQ) | 6.2%
53rd
|
12.2%
79th
|
1.3%
20th
|
| Revenue CAGR, 3 yr | 11.5%
47th
|
23.2%
81st
|
5.3%
29th
|
| Revenue CAGR, 5 yr | 15.2%
54th
|
31.7%
78th
|
5.8%
25th
|
| Gross profit CAGR, 3 yr | 9.4%
38th
|
22.5%
73rd
|
6.2%
28th
|
| Operating income CAGR, 3 yr | 9.8%
35th
|
— | 6.0%
29th
|
| Net income growth (TTM YoY) | 8.7%
35th
|
— | 6.3%
33rd
|
| Net income CAGR, 3 yr | 7.1%
45th
|
— | 6.0%
42nd
|
| EPS growth (TTM YoY) | 17.0%
46th
|
— | 9.7%
31st
|
| EPS CAGR, 3 yr | 11.6%
45th
|
— | 10.8%
42nd
|
| EPS CAGR, 5 yr | 13.5%
46th
|
— | 10.9%
42nd
|
| FCF growth (TTM YoY) | -15.0%
16th
|
178.2%
88th
|
12.2%
41st
|
| FCF CAGR, 3 yr | -0.2%
12th
|
145.3%
98th
|
7.6%
24th
|
| Operating cash flow CAGR, 3 yr | 0.6%
9th
|
140.4%
96th
|
7.6%
18th
|
| Book value CAGR, 3 yr | 7.1%
48th
|
42.8%
87th
|
— |
| Dividend CAGR, 3 yr | — | — | 66.4%
100th
|
| Sustainable growth rate | 30.5%
82nd
|
2.0%
12th
|
— |
Margin history & stability
7 measures| Measure | CPAY | MDB | VRSN |
|---|---|---|---|
| Gross margin, 3-yr average | 76.6%
71st
|
73.0%
56th
|
87.9%
100th
|
| Operating margin, 3-yr average | 43.3%
97th
|
-7.9%
21st
|
67.8%
100th
|
| Net margin, 3-yr average | 24.8%
90th
|
-4.5%
26th
|
51.7%
100th
|
| FCF margin, 3-yr average | 45.6%
99th
|
14.3%
47th
|
58.5%
100th
|
| Revenue stability (0-1) | 0.97
52nd
|
0.99
78th
|
0.99
82nd
|
| Earnings stability (0-1) | 0.93
91st
|
0.83
75th
|
0.55
47th
|
| Margin stability (0-1) | 0.97
57th
|
0.98
77th
|
0.99
91st
|
Liquidity (latest quarter)
7 measures| Measure | CPAY | MDB | VRSN |
|---|---|---|---|
| Cash & short-term investments | $3.2B
84th
|
$2.4B
80th
|
$1.0B
58th
|
| Net cash (− = net debt) | −$7.5B
6th
|
$2.4B
94th
|
−$1.3B
21st
|
| Working capital | −$475.1M
7th
|
$2.5B
93rd
|
−$776.8M
6th
|
| Current ratio | 0.97
21st
|
4.87
93rd
|
0.59
4th
|
| Quick ratio | 0.97
21st
|
4.87
92nd
|
0.59
4th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.19
6th
|
3.75
93rd
|
0.54
32nd
|
| Defensive interval (days) | 1,814 days
88th
|
514 days
53rd
|
1,098 days
83rd
|
Leverage & solvency (latest quarter)
13 measures| Measure | CPAY | MDB | VRSN |
|---|---|---|---|
| Total debt | $10.6B
95th
|
$28.6M
15th
|
$2.3B
74th
|
| Debt / equity | 3.00
88th
|
0.01
7th
|
— |
| Net debt / equity | 2.11
90th
|
−0.80
19th
|
— |
| Debt / assets | 37.6%
60th
|
0.8%
5th
|
129.8%
99th
|
| Debt / capital | 75.0%
87th
|
1.0%
7th
|
— |
| Debt / EBITDA | 4.16
75th
|
0.25
18th
|
1.95
46th
|
| Net debt / EBITDA | 2.92
79th
|
−21.23
3rd
|
1.09
66th
|
| Interest coverage (EBIT / interest) | 4.8x
55th
|
30.0x
85th
|
15.5x
75th
|
| Cash interest coverage | 4.2x
25th
|
261.8x
93rd
|
14.5x
52nd
|
| Debt payback (years of OCF) | 5.8 yrs
82nd
|
0.0 yrs
4th
|
2.1 yrs
47th
|
| Liabilities / assets | 87.3%
74th
|
21.1%
7th
|
225.0%
100th
|
| IS credit model rating | BB- | AAA | BBB- |
| Implied credit spread (bps) | 550
75th
|
50
0th
|
350
59th
|
Efficiency
11 measures| Measure | CPAY | MDB | VRSN |
|---|---|---|---|
| Asset turnover | 0.21
11th
|
0.76
74th
|
1.06
90th
|
| Fixed asset turnover | 10.63
53rd
|
43.63
90th
|
7.50
35th
|
| Inventory turnover | — | — | — |
| Receivables turnover | 1.5
1st
|
6.9
61st
|
223.3
100th
|
| Days sales outstanding | 251 days
99th
|
53 days
40th
|
2 days
1st
|
| Days inventory outstanding | — | — | — |
| Days payables outstanding | 580 days
100th
|
7 days
11th
|
20 days
30th
|
| Cash conversion cycle (days) | −329 days
0th
|
46 days
64th
|
−18 days
23rd
|
| Capex / revenue | 4.2%
74th
|
0.3%
4th
|
2.1%
50th
|
| Capex / depreciation | 0.47
51st
|
0.22
27th
|
1.30
84th
|
| Operating expense ratio | 44.3%
37th
|
70.1%
72nd
|
20.3%
11th
|
Cash flow & earnings quality
7 measures| Measure | CPAY | MDB | VRSN |
|---|---|---|---|
| Operating cash flow / net income | 1.62
42nd
|
11.46
91st
|
1.30
22nd
|
| FCF / net income | 1.44
42nd
|
11.33
92nd
|
1.25
31st
|
| FCF / operating cash flow | 88.7%
47th
|
98.9%
96th
|
96.8%
77th
|
| Capex / operating cash flow | 11.3%
53rd
|
1.1%
4th
|
3.2%
23rd
|
| Accruals ratio | -2.9%
83rd
|
-16.8%
17th
|
-15.7%
22nd
|
| Sloan accruals ratio | -8.4%
31st
|
1.5%
69th
|
-14.1%
17th
|
| Earnings quality score (0-1) | 1.00
73rd
|
0.75
11th
|
0.75
11th
|
Scores & forensic checks
15 measures| Measure | CPAY | MDB | VRSN |
|---|---|---|---|
| IS score | 54
42nd
|
74
85th
|
56
47th
|
| IS profitability | 80
85th
|
30
36th
|
80
86th
|
| IS growth | 64
48th
|
75
72nd
|
60
40th
|
| IS value | 42
59th
|
32
38th
|
44
65th
|
| IS momentum | 87
64th
|
100
95th
|
78
46th
|
| IS risk (safety) | 30
21st
|
100
67th
|
0
0th
|
| IS quality | 67
48th
|
74
65th
|
75
68th
|
| IS balance sheet | 36
23rd
|
96
99th
|
55
42nd
|
| IS earnings quality | 69
73rd
|
50
30th
|
67
62nd
|
| IS cash flow | 70
52nd
|
93
90th
|
81
68th
|
| Piotroski F-score (0-9) | 7
58th
|
7
58th
|
6
36th
|
| Altman Z-score | 1.5
27th
|
21.7
98th
|
−2.8
0th
|
| Beneish M-score | −2.41
70th
|
−2.95
20th
|
−3.30
4th
|
| Ohlson O-score | −6.00
65th
|
−12.05
2nd
|
0.97
100th
|
| IS credit score | 39
25th
|
96
99th
|
52
38th
|
Size (TTM)
8 measures| Measure | CPAY | MDB | VRSN |
|---|---|---|---|
| Market cap | $26.3B
81st
|
$27.2B
83rd
|
$27.3B
84th
|
| Revenue | $5.0B
83rd
|
$2.8B
69th
|
$1.7B
58th
|
| EBITDA | $2.6B
93rd
|
$112.2M
35th
|
$1.2B
84th
|
| Net income | $1.1B
93rd
|
$58.9M
42nd
|
$850.0M
85th
|
| Free cash flow | $1.6B
91st
|
$667.3M
75th
|
$1.1B
84th
|
| Total assets | $28.2B
93rd
|
$3.8B
62nd
|
$1.8B
44th
|
| Shareholders' equity | $3.5B
84th
|
$3.0B
81st
|
−$2.3B
4th
|
| Employees | 11,800
93rd
|
5,783
74th
|
927
15th
|
Price performance
9 measures| Measure | CPAY | MDB | VRSN |
|---|---|---|---|
| 1 day | −1.6% | −7.9% | −0.6% |
| 1 week | +0.5% | −12.5% | −0.5% |
| 1 month | −1.1% | −14.2% | +0.1% |
| 3 months | +8.2% | +4.4% | +9.2% |
| 6 months | +19.4% | +28.2% | +10.9% |
| Year to date | +33.0% | −15.5% | +26.9% |
| 1 year | +38.9% | +6.2% | +15.2% |
| 3 years, cumulative | +56.0% | −7.6% | +46.5% |
| 5 years, cumulative | +52.2% | −24.8% | +49.5% |
Technicals
4 measures| Measure | CPAY | MDB | VRSN |
|---|---|---|---|
| RSI 14 | 50.0 | 39.2 | 59.6 |
| From 52-week high | −6.5% | −28.6% | −3.0% |
| From 52-week low | +58.1% | +56.5% | +46.1% |
| Beta | 0.89 | 1.58 | 0.69 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17